Products for Research Use Only
RegisterLogin

Cholic acid (sodium)

CAT: 0804-HY-N0324A-01Size: 1 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N0324A-01Size:1 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active[1][2].
CAS Number
361-09-1
Product Name Alternative
Sodium cholate
UNSPSC
12352211
Hazard Statement
H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/cholic-acid-sodium.html
Purity
99.85
Solubility
H2O : 116.67 mg/mL (ultrasonic)
Smiles
C[C@H](CCC(O[Na])=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@@]21C
Molecular Formula
C24H39NaO5
Molecular Weight
430.55
Precautions
H315, H319, H335
References & Citations
[1]Li Y, et al. Mechanism of hepatic targeting via oral administration of DSPE-PEG-Cholic acid-modified nanoliposomes. Int J Nanomedicine. 2017 Feb 28;12:1673-1684.|[2]Pan X, et al. Cholic acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice. Drug Metab Dispos. 2017 Apr;45 (4) :346-352.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Natural Products
Clinical Information
Launched
Isoform
Human Endogenous Metabolite
Citation 01
Adv Mater. 2025 Apr;37 (17) :e2416349.|Cell Rep. 2025 Sep 17;44 (10) :116306.|Adv Sci (Weinh) . 2025 Feb 3:e2411719.|Aquaculture. 2023 Sep 18, 740123.|Cancer Cell. 2024 Aug 12;42 (8) :1386-1400.e8.|Cell Host Microbe. 2024 Feb 14;32 (2) :191-208.e9.|Cell Host Microbe. 2025 Aug 19:S1931-3128 (25) 00291-4.|Cell Res. 2019 Mar;29 (3) :193-205. |Front Cell Dev Biol. 2022 Jul 22:10:854425.|J Adv Res. 2024 Sep 5:S2090-1232 (24) 00389-8.|J Enzyme Inhib Med Chem. 2025 Dec;40 (1) :2501743.|J Pharm Biomed Anal. 2025 Jul 15:259:116760.|J Transl Med. 2024 Dec 20;22 (1) :1124.|J Voice. 2025 Nov 29:S0892-1997 (25) 00490-4.|Microb Pathog. 2026 Jan:210:108187.|Mol Neurobiol. 2024 Nov;61 (11) :9302-9319.|Nature. 2025 Jul;643 (8070) :192-200.|Research (Wash D C) . 2025 Jun 24:8:0741. |Transl Cancer Res. 2025 Aug 31;14 (8) :4774-4790.

Related Products

CatalogName
HY-126855A-01Cholic acid 7-sulfate (sodium)
HY-W1002768-01Cholic acid 3-sulfate (sodium)
HY-N0324-01Cholic acid
HY-156191-01Cholic acid anilide
HY-N0324S1-01Cholic acid-d5
HY-W585922-013β-Cholic acid
HY-N0324S2-01Cholic acid-13C
HY-N0324S-01Cholic acid-d4
HY-174300Cholic acid-Glu
HY-N15721-01Tryptophan-cholic acid

Alternative Products

CatalogName
GTR19170646Cholic acid sodium
MBS5817349Cholic acid sodium hydrate
BA 2202-01Cholic Acid, Sodium Salt
FC14775-01Cholic acid sodium salt
GTR19247650-01Cholic acid sodium monohydrate
TN11564-01Cholic acid 3-sulfate sodium
GD5134-250gCholic acid sodium salt hydrate
TN11554-01Cholic acid 7-sulfate sodium
15562390-100gCholic acid sodium salt (C24H39NaO5)

Popular Products